Related Experiment Videos
Multi-tissue integrated Mendelian randomization method identifies disease risk genes
Yu Cheng1, Shuhan Liu1, Xinjia Ruan1
1Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, No. 639 Longmian Ave, Jiangning District, Nanjing 211100, Jiangsu, China.
Briefings in Bioinformatics
|July 28, 2026
Summary
This study introduces MULTI, a novel Bayesian framework for Mendelian randomization (MR) that integrates multi-tissue genetic data. MULTI enhances causal inference accuracy for disease risk genes, even with limited single-tissue instruments.
Area of Science:
- Genetics
- Bioinformatics
- Statistical genetics
Background:
- Mendelian randomization (MR) uses genetic variants to infer causality between molecular traits and diseases.
- Identifying specific causal genes for disease risk using MR remains a significant challenge.
Purpose of the Study:
- To present MULTI (Multi-tissue Unified Likelihood-based Transcriptomic Integration), a Bayesian MR framework.
- To improve causal inference accuracy by integrating genetic information across multiple tissues.
- To enhance statistical power and identify tissue-specific causal mechanisms.
Main Methods:
- Developed a Bayesian MR framework named MULTI.
- Integrated genetic information across multiple tissues.
- Employed adaptive tissue information integration to boost power without increasing type I error rates.
Main Results:
- MULTI provides reliable causal inference estimates, even with limited instruments in a single tissue.
- The framework adaptively integrates information from similar tissues, increasing statistical power.
- Simulations confirmed MULTI's robustness across various genetic architectures.
- Real-data applications revealed tissue-specific causal mechanisms and cross-tissue regulation.
Conclusions:
- MULTI offers a practical and extensible framework for causal gene discovery in complex diseases.
- The method aids in elucidating the molecular architecture underlying human diseases.
- Facilitates a deeper understanding of tissue-specific and coordinated regulatory mechanisms in disease etiology.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...